网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
YBX1和KPNA2在肺鳞癌中的表达及其临床意义
作者:寇凯鹏  于一  王青霞 
单位:铜川市人民医院 呼吸与危重症医学科, 陕西 铜川 727000
关键词:肺鳞癌 Y-盒结合蛋白1 核转运蛋白α2 临床病理特征 预后 
分类号:R734.2
出版年·卷·期(页码):2021·49·第八期(926-931)
摘要:

目的:探讨Y-盒结合蛋白1(YBX1)和核转运蛋白α2(KPNA2)在肺鳞癌中的表达及其临床意义。方法:选取本院2015年1月至2017年5月收治的137例肺鳞癌患者进行研究,术中收集肺鳞癌组织及相应癌旁组织,采用免疫组化染色法检测肺鳞癌组织、癌旁组织中YBX1、KPNA2表达情况,采用乘积极限(K-M)法进行生存分析,Log-rank检验比较显著性;COX回归模型分析影响肺鳞癌患者预后生存状态的因素。结果:与癌旁组织相比,肺鳞癌组织中YBX1、KPNA2阳性表达率较高(P<0.05);肺鳞癌组织中YBX1、KPNA2表达与肿瘤分化程度、临床分期、淋巴结转移有关(P<0.05);Spearman相关分析显示,肺鳞癌组织中YBX1与KPNA2表达呈正相关(r=0.508,P<0.05);随访期内肺鳞癌患者死亡率为37.23%,与YBX1、KPNA2阴性表达者相比,YBX1、KPNA2阳性表达者死亡率较高(P<0.05),总生存期较短(P<0.05);多因素COX分析结果显示,YBX1阳性表达、KPNA2阳性表达、肿瘤分期为Ⅲ期、伴淋巴结转移是影响肺鳞癌患者预后生存状况的独立危险因素(P<0.05)。结论:肺鳞癌组织中YBX1、KPNA2阳性表达与患者肿瘤分化程度、临床分期、淋巴结转移有关,YBX1、KPNA2有望用于评估肺鳞癌患者病情演变及预后状况。

Objective: To investigate the expression and clinical significance of Y-box binding protein 1(YBX1) and karyopherin alpha 2(KPNA2) in lung squamous cell carcinoma. Methods: A total of 137 patients with lung squamous cell carcinoma admitted to our hospital from January 2015 to May 2017 were selected for the study, lung squamous cell carcinoma tissues and corresponding adjacent tissues were collected during the operation. Immunohistochemical staining was used to detect the expression of YBX1 and KPNA2 in lung squamous cell carcinoma and adjacent tissues, and the expression of YBX1 and KPNA2 in lung squamous cell carcinoma and adjacent tissues was compared; the relationship between the expression of YBX1 and KPNA2 in lung squamous cell carcinoma and the clinicopathological features was analyzed; the product limit(K-M) method was used for survival analysis, Log-rank test was used to compare the significance; COX regression model was used to analyze the factors influencing the prognostic of patients with lung squamous cell carcinoma. Results: In contrast to parcancer tissue, YBX1, KPNA2 positive expression in pulmonary squamous carcinoma(P<0.05); YBX1, KPNA2 expression in pulmonary squamous carcinoma tissue was related with degree of tumor differentiation, clinical staging, lymph node metastasis(P<0.05). The Spearman-related analysis shows that, YBX1 was positively associated with KPNA2 expression in pulmonary squamous carcinoma tissue(r=0.508, P<0.05). During the follow-up period, the mortality of lung squamous cell carcinoma was 37.23%. In contrast to the YBX1, KPNA2-negative expression person, High YBX1, KPNA2-positive expression mortality(P<0.05), Short total survival period(P<0.05); Multi-factor COX analysis results showed that, YBX1 positive expression, KPNA2 positive expression, the tumor stage was stage Ⅲ, and associated lymph node metastasis were independent risk factors affecting the prognosis survival of patients with pulmonary squamous carcinoma(P<0.05).Conclusion: The positive expressions of YBX1, KPNA2 in lung squamous carcinoma tissue is related to degree of tumor differentiation, clinical stage and lymph node metastasis. YBX1, KPNA2 expected for evaluationthe evolution and prognosis of pulmonary squamous carcinoma patients.

参考文献:

[1] 李伟婷, 李永文, 张洪兵, 等.基于TCGA数据库的中央型与周围型肺鳞癌基因表达差异性研究[J]. 中国肺癌杂志, 2019, 22(5):280-288.
[2] 徐凌, 程宇, 任静, 等.124例肺鳞癌患者的临床病理特征及预后因素分析[J]. 临床肺科杂志, 2020, 25(7):1008-1013.
[3] 汪亚玲, 朱月芳, 杨先甲.卵巢癌组织中YB1和CD44蛋白表达及与卵巢癌患者临床特征的关系[J]. 癌症进展, 2019, 17(9):1072-1074, 1114.
[4] JEFFORDS E, FREEMAN S, COLE B, et al. Y-box binding protein 1 acts as a negative regulator of stearoyl CoA desaturase 1 in clear cell renal cell carcinoma[J]. Oncol Lett, 2020, 20(5):165-176.
[5] 汪圣毅, 张永红, 闫亚飞, 等.胃癌化疗抵抗基因PMP22下游的生物信息学机制[J]. 安徽医科大学学报, 2019, 54(4):509-514.
[6] 马春艳.结直肠癌组织中核运转蛋白KPNA2的表达及其与结直肠癌临床病理特征之间的关系[J]. 河北医学, 2020, 26(2):197-201.
[7] 薛美玲, 张雪, 段秀庆.核转运蛋白基因2在乳腺癌发生发展中的作用[J]. 医学综述, 2020, 26(14):2775-2779.
[8] 张淑莲, 马军, 齐宝华, 等.核转运蛋白α2(KPNA2)通过激活Snail1信号通路促进胃癌细胞增殖和侵袭及迁移[J]. 细胞与分子免疫学杂志, 2020, 36(5):430-437.
[9] HUANG L, ZHOU Y, CAO X P, et al. KPNA2 promotes migration and invasion in epithelial ovarian cancer cells by inducing epithelial-mesenchymal transition via Akt/GSK-3β/Snail activation[J]. J Cancer, 2018, 9(1):157-165.
[10] LIANG C, MA Y L, YONG L, et al. Y-box binding protein-1 promotes tumorigenesis and progression via the epidermal growth factor receptor/AKT pathway in spinal chordoma[J]. Cancer Sci, 2019, 110(1):166-179.
[11] 王弘, 张坤, 李爽, 等.沉默Y盒结合蛋白-1表达抑制SH-SY5Y细胞增殖促其凋亡的作用与机制[J]. 现代肿瘤医学, 2018, 26(1):13-17.
[12] LIU Z, LI Y, LI X, et al. Overexpression of YBX1 promotes pancreatic ductal adenocarcinoma growth via the GSK3B/Cyclin D1/Cyclin E1 pathway[J]. Mol Ther Oncolytics, 2020, 17(1):21-30.
[13] MARTINEZ-OLIVERA R, DATSI A, STALKAMP M, et al. Silencing of the nucleocytoplasmic shuttling protein karyopherin a2 promotes cell-cycle arrest and apoptosis in glioblastoma multiforme[J]. Oncotarget, 2018, 9(71):33471-33481.
[14] LIN F, GAO L, SU Z Y, et al. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation[J]. Oncol Rep, 2018, 40(1):179-194.
[15] MVLLER T, TOLKACH Y, STAHL D, et al. Karyopherin Alpha 2 is an adverse prognostic factor in clear-cell and papillary renal-cell and papillary renal-cell carcinoma[J]. Clin genitourin Cancer, 2019, 17(1):167-175.
[16] YU Y N, YIP G W C, TAN P H, et al. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle[J]. Int J Oncol, 2010, 37(2):483-492.
[17] 王昕晨, 黄燕燕, 陆畅畅, 等.mTOR信号通路相关分子在肺鳞癌组织中表达的意义[J]. 浙江医学, 2020, 42(16):1689-1693.
[18] 孙倩, 李舒展, 魏枫, 等.CD200R在肺鳞状细胞癌组织中的表达及其临床意义[J]. 中国肿瘤临床, 2019, 46(19):977-981.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 510041 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541